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Available online 2 April 2016Placental amino acid transfer is essential for fetal development and its impairment is associated with poor fetal
growth. Amino acid transfer is mediated by a broad array of speciﬁc plasmamembrane transporters with overlap-
ping substrate speciﬁcity. However, it is not fully understood how these different transporterswork together tome-
diate net ﬂux across the placenta. Therefore the aim of this study was to develop a new computational model to
describe how human placental amino acid transfer functions as an integrated system. Amino acid transfer from
mother to fetus requires transport across the two plasma membranes of the placental syncytiotrophoblast, each
of which contains a distinct complement of transporter proteins. A compartmental modelling approach was com-
binedwith a carrier basedmodelling framework to represent the kinetics of the individual accumulative, exchange
and facilitative classes of transporters on each plasma membrane. The model successfully captured the principal
features of transplacental transfer. Modelling results clearly demonstrate how modulating transporter activity
and conditions such as phenylketonuria, can increase the transfer of certain groups of amino acids, but that this
comes at the cost of decreasing the transfer of others, which has implications for developing clinical treatment op-
tions in the placenta and other transporting epithelia.
© 2016 The Authors. Published by Elsevier B.V. This is an open access article under the CC BY license
(http://creativecommons.org/licenses/by/4.0/).Keywords:
Amino acids
Placenta
Epithelial transport
Mathematical model1. Introduction
The placenta is the interface between the maternal and fetal circula-
tions and plays an essential role in mediating the transfer of all the nutri-
ents required for fetal development, including amino acids. Impaired
placental transfer of amino acids during pregnancy is associated with
poor fetal growth, which increases the risk of poor pregnancy outcomes
such as stillbirth [1] and of chronic disease in adult life [2–4]. There are
currently no effective treatments for fetal growth restriction (FGR) and
a better understanding of placental transfer as a whole could potentially
contribute to the development of treatment strategies for intervention
and prevention of the disease.
Transfer of amino acids across the placenta is a complex process, inﬂu-
enced by multiple factors including placental blood ﬂow, membrane
transporters, intracellular metabolism and placental morphology [5,6]. Inighﬁeld Campus, Southampton,
).
. This is an open access article underorder to pass from thematernal intervillous space into the fetal capillaries,
amino acids need to cross the placental syncytiotrophoblast, an epithelial
barrier separating the two circulations. Amino acids in thematernal blood
ﬁrst need to be transported across the microvillous plasma membrane
(MVM) of the placental syncytiotrophoblast into the cytosol. They can
then either undergo metabolism or can be transported across the fetal-
facing basal plasma membrane (BM), from where it is assumed they dif-
fuse across the fetal capillary endothelium to the fetal circulation [6].
Amino acid transport across theMVM and BM is mediated by speciﬁc
transport proteins [6], which operate using different energetically passive
and active transport mechanisms. Accumulative transporters actively
pump amino acids into the placental syncytiotrophoblast against their
concentration gradient, using secondary active transport drivenby the so-
dium electrochemical gradient. This serves as an important driving force
for amino acid transfer as a whole, since fetal amino acid concentrations
are higher than maternal concentrations [7] and syncytiotrophoblast cy-
tosol concentrations are higher than both [8]. Exchangers (antiporters)
are another important class of transporter, which take one amino acid
from outside of the plas`ma membrane and swap it for another amino
acid from inside the syncytiotrophoblast. Thus, exchangers mediatethe CC BY license (http://creativecommons.org/licenses/by/4.0/).
Fig. 1.Compartmentalmodel of the placental amino acid transfer system, representing the
volumes of the maternal intervillous space (vm), placental syncytiotrophoblast (vs), and
fetal capillaries (vf). Amino acid transporters included at the maternal-facing
microvillous membrane (MVM) were accumulative transporter (Ac) and exchanger
(Ex), and those at the fetal-facing basal membrane (BM) were facilitative transporter
(F) and exchanger (Ex). Fm and Ff are the ﬂow inputs (and outputs) in the maternal and
fetal compartments respectively. [A] and [B] indicate amino acid concentrations in the
various compartments.
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amount. Facilitative transporters on the other hand are responsible for
mediating net transport to the fetus, via facilitative diffusion driven by
the amino acid electrochemical gradients [9,10].
Critically, these three classes of transporter need to work together to
mediate net transfer of all the required amino acids to the fetus, as it is
not possible for one to do so alone [9,11]. For example, substrates taken
up by the accumulative transporter across the MVM can be exchanged
back to the mother to drive uptake by exchangers of amino acids that
are not substrates of the accumulative transporter. Similarly, the ex-
changers at the BM transfer amino acids to the fetus that are not sub-
strates of the facilitative transporters.
Whilemany studies of amino acid transfer have focussed on individu-
al transporters, the integrated study of the interactions betweenmultiple
transporters in the two placental plasmamembranes has been limited [9,
12]. There are twenty amino acids, which can either inhibit or promote
each other's transport, andmany distinct transporter proteins with over-
lapping substrate speciﬁcity. Hence, given this inherent complexity, a sys-
tems approach using mathematical modelling is necessary to help
describe the transport process as a whole. Previous placental models
have mainly focussed on blood ﬂow and oxygen transport by simple dif-
fusion, which has proved highly valuable to explain placental structure–
function relationships [13–17], while models for membrane transport
have been applied for the placental transfer of drugs [18] and glucose
[19]. We have previously introduced a model of human placental amino
acid transfer, applied to the uptake and exchange of serine and alanine
[20]. However, a systematic integrated analysis of amino acid transfer is
required, including more mechanistic transporter models [6,21,22].
The aim of this study was to develop a modelling framework for
human placental amino acid transfer as an integrated system, to better
understand (i) how different types of transporter work together,
(ii) how composition of amino acids affects transport, and (iii) how spe-
ciﬁc transporter activities can drive net transfer of all amino acids to the
fetus.
2. Methods
2.1. Compartmental model for the placenta
A compartmental modelling approach was adopted based on our
previouswork [20], inwhich the placentawas represented as three sep-
arate volumes, corresponding to the maternal intervillous space,
syncytiotrophoblast, and fetal capillaries respectively (Fig. 1). All com-
partments were assumed to be well mixed, as the main focus is on the
transporter interactions. The transfer of amino acids between compart-
ments was modelled as ﬂuxes mediated by the various types of trans-
porters [9]. In each membrane (MVM and BM), transport by a certain
type of transporter was combined and modelled as a single representa-
tive transporter. At the maternal-facing MVM these included transport
by an accumulative and an exchange transporter, while at the fetal-fac-
ing BM transport by a facilitative and an exchange transporter (Fig. 1).
Note that accumulative transporters are also found on the BM, but
these were not included in the model as their role is thought to be lim-
ited [11]. Details of the model implementation are described below.
The rate of change in the concentration of a certain amino acid A
within each placental compartment is given by:
d A½ m
dt
¼ 1
vm
JmA; flow  Jm→sA;ac  Jm→sA; ex
 
ð1Þ
d A½ s
dt
¼ 1
vs
Jm→sA;ac þ Jm→sA;ex  Js→ fA;ex  Js→ fA; fa
 
ð2Þ
d A½  f
dt
¼ 1
vf
J fA; flow þ Js→ fA;ex þ Js→ fA;fa
 
ð3Þwhere [A]i is the concentration (mol l−1) of substrate A in compartment
i, and vi is the compartment volume (l). JAi→j represent the net molecular
ﬂux (mol min−1) of A from compartment i to j. Herem, s, and f, are the
maternal, syncytiotrophoblast and fetal compartments respectively,
while ac, ex, and fa denote the accumulative, exchange, and facilitative
transporters. JA ,ﬂowi is the net molecular ﬂux (mol min−1) due to blood
ﬂow.
2.2. Classiﬁcation of amino acids in representative groups
Amino acids were categorised according to their transporter speci-
ﬁcity into four generic groups, to reduce complexity in theﬁrst instance.
As shown in Table 1, these representative amino acid groupswere AcEx,
substrate of the accumulative and exchange transporters; Ex, exchange
only substrate; ExF, substrate of exchange and facilitative transporters;
and AcExF, substrate of all transporter types. Normal physiological con-
centrations of amino acids [7,8] were summed per representative group
in each compartment. Glutamate and aspartatewere not included in the
model as these are taken up by distinct transport systems (EAATs) and
their interactions with the transfer of other amino acids would be ex-
tremely limited.
2.3. Individual transporter models
Models for each type of transporter were developed based on the
principles of carrier-mediated transport [21,23], to represent the simul-
taneous transport of multiple substrates. Brieﬂy, parameters describing
the kinetic properties were kept to the minimum required to represent
the functional activity of each transporter type. Therefore, in the ﬁrst in-
stance, exchanger and facilitative transporter translocation rate con-
stants were assumed to be symmetric and binding afﬁnities equal on
both sides of the plasma membrane. In addition, substrates of a certain
type of transporter were all assumed to have identical kinetic and bind-
ing properties.
Table 1
Amino acids groups distinguished in the model as categorised by transporter speciﬁcity and their physiological concentrations [7,8]a.
Amino acid group Transporter speciﬁcity Name Maternal concentration
(μmol l−1) [7]
Syncytiotrophoblast
concentration
(μmol l−1) [8]
Umbilical artery
concentration
(μmol l−1) [7]
Umbilical vein
concentration
(μmol l−1) [7]
AcEx Accumulative and exchange Arginine 51 320 101 108
Glutamine 368 1135 482 494
Glycine 107 1655 217 218
Histidine 85 74 108 119
Lysine 131 508 317 343
Serine 84 721 144 142
Sum 826 4413 1369 1424
Ex Exchange Threonine 170 786 258 270
ExF Exchange and facilitative Isoleucine 43 105 56 63
Leucine 81 305 105 120
Phenylalanine 39 173 63 65
Tyrosine 34 220 59 59
Valine 141 342 200 216
Sum 338 1145 483 523
AcExF Accumulative, exchange,
and facilitative
Alanine 215 1987 238 282
Values indicated in bold represent the total concentrations for each amino acid group used in the model.
a Note, glutamate and aspartate were excluded as these are taken up by distinct transport systems. Asparagine, proline andmethioninewere not included as the data sets used did not
contain values for all three compartments.
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For the exchanger withmultiple substrates, the net ﬂux of substrate
A from compartment I to II (mol min−1) is given by [24]:
JI→IIA;ex ¼ Vex
A½ I R½ II  A½ II R½ I
Kex Tot½ I þ Tot½ II
 
=2þ Tot½ I Tot½ II
ð4Þ
where [A]i is the concentration of substrate A (mol l−1) in compartment
I or II, [Tot]i is the total sum of all exchanger substrates, while [R]i de-
notes the sum of all exchanger substrates, but excluding substrate A in
compartment i. Kex is the dissociation constant (mol l−1), assumed
equal for all substrates of the exchanger, and Vex is themaximum trans-
port rate (mol min−1).
2.3.2. Facilitative transporter model
For the facilitative transporter with multiple substrates, the net ﬂux
of substrate A from compartment I to II (mol min−1) is given by [24]:
JI→IIA;fa ¼ Vfa
A½ I
Kfa þ Tot½ I
 A½ 
II
Kfa þ Tot½ II
 !
ð5Þ
where [A]i is concentration of substrate A (mol l−1) in compartment i,
[Tot]i is the sum of the concentrations of all substrates of the facilitative
transporter in compartment i. Kfa is the dissociation constant (mol l−1),
assumed equal for all substrates of the facilitative transporter, and Vfa is
the maximum transport rate (mol min−1).
2.3.3. Accumulative transporter model
Accumulative transporters operate via secondary active transport
driven by the sodium electrochemical gradient. A cotransport model
was adopted [24], in which it was assumed that sodium binds to the
transporter ﬁrst, followed by the amino acid [25] and that only the
translocation of the carrier-sodium-substrate complex was electrogen-
ic. The net ﬂux of substrate A from compartment I to II (mol min−1) is
given below for the model distinguishing two different substrates:
JI→IIA;ac ¼
Vac
D=2
εε0 Na½ I Na½ II A½ I B½ II− A½ II B½ I
 
þ KacKNa ε0 A½ I Na½ I−ε A½ II Na½ II
 n o
D ¼ Na½ I Na½ II ε0 Tot½ I Tot½ II þ Kac
 
þ ε Tot½ II Tot½ I þ Kac
  
þ KacKNa ε0 þ 1
 
Tot½ I Na½ I þ ε þ 1ð Þ Tot½ II Na½ II
 
þ Kac2KNa Na½ I þ Na½ II
 
þ 2 KacKNað Þ2
ε ¼ e βzFRTΔψð Þ andε0 ¼ e β−1ð ÞzFRT Δψð Þ
ð6Þwhere [A]i and [B]i are the concentrations (mol l−1) of substrate A and B
in compartment i, [Tot]i is the sum of substrates A and B. Kac and KNa rep-
resent the dissociation constants (mol l−1) of the amino acid substrates
and sodium, respectively, and Vac is the transport rate constant
(mol min−1). The electrical potential induced bias was given by ε′ and
ε for the forward and backward transport rate, respectively [26]. β rep-
resents the electrical bias constant, z is the charge of sodium, F is the Far-
aday constant, R is the gas constant, T is the absolute temperature and
ΔΨ is themembrane potential difference between side I and II (Table 2).
2.4. Compartmental blood ﬂow
Blood ﬂow in and out of the maternal and fetal compartments was
modelled as constant (non-pulsatile). Compartments were assumed
well mixed, with ﬂow resulting in a net molecular ﬂux (mol min−1)
as follows:
JiA;flow ¼ Fi A½ iin  A½ i
 
ð7Þ
where [A]iin is the input concentration (mol l−1) of substrate A in com-
partment i and [A]i is the concentration in the compartment. Fi is the
ﬂow rate in and out of compartment i (l min−1).
2.5. Model parameters
Reference parameters are reported in Table 2. In general, the param-
eters selected were for normal physiological conditions. A single func-
tional unit of the placenta (cotyledon) was modelled with a volume of
30 ml (~30 g), as described previously [20,27]. For the transporter
models, the transport rate constants V were initially taken equal for
each class of transporter to clearly evaluate their inﬂuence on the sys-
tem [20].
2.6. Numerical implementation
All models were implemented in Matlab (R2014a). To predict the
concentrations of amino acids in each compartment, time integration
of Eqs. (1)–(3) was performed using the ode45 function (Runge–Kutta
(4, 5) method). Sensitivity analyses for the different model parameters
were carried out based on steady state values of fetal amino acid
transfer.
Table 2
Reference parameter values.
Parameter Value Unit Reference
Compartmental model:
Total placental cotyledon volume 30 ml [10,20]
% maternal volume (intervillous space) 34% – [20,27]
% syncytiotrophoblast volume 15% – [20,27]
% fetal volume (fetal capillaries) 7.5% – [20,27]
Maternal blood ﬂow rate 2 ml min−1 g−1 [28]
Fetal blood ﬂow rate 0.2 ml min−1 g−1 [29]
Transporter models:
Accumulative
Effective transport rate, Vac 0.005 mmol min−1 [20]
Charge of sodium ion, z 1 – –
Faraday constant, F 9.65 × 104 C mol−1 –
Gas constant, R 8.314 VC K−1 mol−1 –
Body temperature, T 310 K –
Transmembrane potential difference,
ΔΨ
−21 mV [30]
Maternal sodium concentration 134 mmol l−1 [31]a
Syncytiotrophoblast sodium
concentration
15 mmol l−1 [32]b
Electrical bias constant, β 0.33 – [33]c
Substrate dissociation constant, Kac 2.26 mmol l−1 [33]c
Sodium dissociation constant, KNa 25.07 mmol l−1 [33]c
MVM exchanger
Maximum transport rate, Vex,mvm 0.005 mmol min−1 [20]
Substrate dissociation constant, Kex 200 μmol l−1 [34,35]d
BM exchanger
Maximum transport rate, Vex,bm 0.005 mmol min−1 [20]
Substrate dissociation constant, Kex 200 μmol l−1 [34,35]d
Facilitative
Maximum transport rate, Vf 0.005 mmol min−1 [20]
Substrate dissociation constant, Kf 1000 μmol l−1 [36]d
a Mean of lower and upper late pregnancy values.
b Intracellular value for brain as no speciﬁc information available.
c Fitted based on data Yao et al., Fig. 5f [24,33].
d Representative value based on weighted average dissociation constants.
Fig. 2. Model simulations of transport interactions at the MVM using physiological
concentrations (Table 1). MVMEx consists of the sum of all amino acids transported by
exchange only at the MVM, while MVMAcEx consists of the sum of those transported by
exchange as well as accumulative transporters. Solid lines: equal accumulative and
exchange transporter activities. Dashed lines: 10x increased accumulative transport
activity. Note this does not affect equilibrium concentrations. Online version in colour.
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The effective transport rate parameters for each transporter includ-
ed in themodel (Vac, Vex ,mvm, Vex,bm, and Vfa) were ﬁtted simultaneously
based on the relative (normalised) error between the literature and pre-
dicted steady state fetal venous–arterial concentration difference. A
least square criterion was used with all amino acid groups weighted
equally. The ﬁtting procedure was implemented using the fminsearch
function in Matlab (Nelder–Mead method).
3. Results
This section will ﬁrst explore how amino acids are transferred to the
fetus across each syncytiotrophoblast plasma membrane (MVM and
BM) separately. Subsequently, MVM and BM are combined, producing
an integrated representation of how amino acids cross the placenta.
Sensitivity analyses for model parameters are presented to understand
the transport system as a whole and how these affect the different
amino acid groups. Lastly, an example of the impact of a certain genetic
condition with elevated phenylalanine levels (maternal phenylketon-
uria) is explored using the model.
3.1. Uptake of maternal amino acids: transport interactions across the
microvillous plasma membrane
Transport of amino acids across the MVM is mediated by both accu-
mulative and exchange transporters (Fig. 1). While the accumulative
transporters actively pump amino acids into the syncytiotrophoblast,
the exchangers are responsible for equalising their relative composition.The amino acid substrates from Table 1 were categorised further into
two groups according to their transporter speciﬁcity at the MVM: 1) Ac-
cumulative and exchange transporter substrate, MVMAcEx, consisting of
AcEx and AcExF, and 2) Exchanger-only substrate, MVMEx, consisting of
Ex and ExF. Physiological amino acid concentrations (Table 1)were com-
bined and used as initial values for thematernal and syncytiotrophoblast
compartments respectively and as constant input concentrations into
the maternal compartment. Initially, transport across the BM was dis-
abled to clearly demonstrate the potential for uptake across the MVM.
The model showed concentrations in the syncytiotrophoblast rising
well above maternal concentrations for both MVMAcEx and MVMEx
(Fig. 2). This demonstrated that the combined accumulative and ex-
change transporter conﬁguration allowed uptake of both amino acid
groups across the MVM by transporting intracellular MVMAcEx sub-
strates back out again from the syncytiotrophoblast in exchange for ex-
ternal MVMEx substrates. The syncytiotrophoblast concentrations of
both substrate groups rose well above physiological values; however it
is important to note that in this case the model only considered the
MVM transporter activities and did not include efﬂux transport across
the BM, which would lead to a lower equilibrium. Steady state concen-
trations were reached when the opposing gradients in accumulative
transporter substrate and sodium electrochemical potential were equili-
brated and the fraction of exchanger substrates equalised in both com-
partments. Thus, changes in transporter activity did not affect the
equilibrium syncytiotrophoblast concentrations, but only the uptake
rate and thus the speed at which this equilibrium was reached. This
can be observed for the accumulative transporter activity in Fig. 2.
In principle, higher exchanger activity could promote exchange of
MVMAcEx back to the maternal side, leading to slower accumulation
of MVMAcEx amino acids and faster uptake of MVMEx into the
syncytiotrophoblast. However, increasing the exchanger activity by a
factor 10 only had a minor impact, as the relative composition of both
compartments already appeared to be in quasi steady equilibrium at
any moment in time (results not shown).
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plasma membrane
Exchange and facilitative transporters localised to the BM are re-
sponsible for the delivery of amino acids to the fetus. While exchangers
are important in regulating the relative composition of amino acids, it is
the BM facilitative transporters which mediate net delivery of amino
acids to the fetus. Thus, the interactions between these transporters
were explored in Fig. 3. The amino acid concentrations from Table 1
were grouped further according to their transporter speciﬁcity at the
BM: 1) Exchange substrates alone, BMEx, consisting of groups AcEx
and Ex, and 2) Exchange and facilitative substrates, BMExF including
ExF and AcExF. The combined umbilical arterial concentrations were
used as both initial values and input concentrations for the fetal com-
partment, while in this case the syncytiotrophoblast amino acid concen-
trations were kept constant throughout the simulations. The results in
Fig. 3 show an increase in fetal delivery for BMExF, evident from the in-
crease in umbilical vein concentration over time. In contrast, a slight de-
crease in the fetal concentration of BMEx was observed, which implies
reverse transport into the syncytiotrophoblast. This was due to the
higher input fraction of BMEx in the fetal compartment (0.69) than
the fraction in the syncytiotrophoblast (0.62), which led to reverse net
transport due to exchange. However, it was shown that increasing the
facilitative activity (e.g. by 10 fold) can indirectly boost the fetal delivery
of BMEx to the fetus (Fig. 3). This is because the increased efﬂux of
BMExF by the facilitative transporter reduced the fraction of BMEx in
the fetal compartment, and once this fraction was lower than the frac-
tion in the syncytiotrophoblast this then enabled net transfer to the
fetus by the exchanger. However, lowering the fraction of BMEx in
this way required a substantial increase in fetal compartment BMExF
to a concentrationmuch higher than physiological in the umbilical vein.3.3. Transfer across the placenta from mother to fetus
Having separately established the mechanisms of transport at the
BM and MVM, the next step was to consider both membranes simulta-
neously. All three placental compartments were included (Fig. 1) and
model simulations of the four groups of amino acids were generatedFig. 3. Model simulations of transport interactions at the BM using physiological
concentrations (Table 1). BMEx is the sum of all substrates transported by exchange only
at the BM, while BMExF is the sum of all substrates transported by both exchangers and
facilitated transporters. Note that in the model the fetal compartment concentration
equals that in the umbilical vein. Solid lines: equal exchanger and facilitative transporter
activity. Dashed lines: 10x increased facilitative transport activity. For equal activity, the
steady state level of BMEx at the end was slightly lower than the initial and input
concentration, implying reverse transport from the fetal compartment into the
syncytiotrophoblast.using the physiological concentrations from Table 1 as inputs and initial
conditions. The model simulations in Fig. 4 demonstrated that all four
amino acid groups were successfully transferred to the fetal compart-
ment, as evident from a net increase in their umbilical vein concentra-
tions. Using literature values for maternal and fetal plasma as well as
intracellular concentrations, the model appeared to be operating near
steady state, although the amino acid groups AcEx and in particular
AcExF showed reductions from the initial concentrations in the
syncytiotrophoblast. Simulated results at steady state were compared
with the umbilical venous–arterial concentration difference from litera-
ture [7] and appeared to correspond reasonably well on ﬁrst inspection
(Table 3), without any tuning of the model parameters. However, the
model over-predicted transfer for amino acid groups AcExF and ExF to
various degrees and under-predicted AcEx and Ex,with the greatest rel-
ative discrepancy being for Ex.3.4. Effects of individual transporter activities
The effect of varying the relative activity of each transporter type
was explored. Reference transport activity parameters V for the accu-
mulative, MVM exchange, BM exchange, and facilitative transporter
(Table 2) were varied. Increasing the activities of accumulative and fa-
cilitative transporters promoted the placental transfer of all amino
acid groups (Fig. 5a and d), until limits in placental transfer were
reached. Interestingly, the results also showed that while increasing
the activity of particular transporters promoted the transfer of certainFig. 4.Model simulation of amino acid transfer across the placenta, showing the amino
acid concentrations of the different groups of amino acids in each of the placental
compartments. Simulations using physiological amino acid concentrations (Table 1) and
model parameters from Table 2. Results represent the sum of all amino acids in each
group. Note fetal AcExF rises sharply initially before going down again. Results
demonstrated positive fetal delivery for all amino acids at steady state.
Table 3
Umbilical venous–arterial concentration differences for each amino acid group.
Amino acid
group
Reference simulation
(μmol l−1)
Literature [7]
(μmol l−1)
Model ﬁt
(μmol l−1)
AcEx 46 55 53
Ex 2.7 12 9.3
ExF 43.6 40 32.5
AcExF 67.4 44 70
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increasing BM exchanger activity would result in a decrease in fetal de-
livery of amino acids that are transported by facilitative transporters
(ExF and AcExF) (Fig. 5c), since this promotes exchange back into the
syncytiotrophoblast. Similarly, increasing MVM exchanger activity pro-
moted uptake and fetal delivery of those amino acids that are
transported by exchange only at the MVM (Ex and ExF) at the expense
of AcEx (Fig. 5b), which is taken up by the accumulative transporter and
exchanged back into thematernal compartment. However, surprisingly
an increase in placental transferwas observed for AcExF (Fig. 5b),which
has the same accumulative-exchange transporter speciﬁcity at the
MVM as AcEx. This is because in the reference simulation the
syncytiotrophoblast fraction of AcExF dropped from a high initial ratio
of 0.24 down to 0.11 at steady state, which is lower than the ratio of
0.14 on the maternal side. Increasing MVM exchange activity would
then promote AcExF uptake into the syncytiotrophoblast compartment
and in turn increase transfer to the fetal compartment by facilitated
transport. Thus, MVM exchangers affected BM transfer indirectly, and
in opposite manners depending on how the overall transport system
shifted the concentration ratios of each amino acid in the three com-
partments. Lastly, it can be noted from Fig. 5a–d that the placental trans-
fer of amino acid Ex (transported by exchanger only) could be driven by
increasing any transporter activity, but only to a small degree. Negative
fetal delivery, corresponding to amino acid transport out of the fetalFig. 5. Individual transporter activity sensitivity analysis. Fetal venous–arterial difference
at steady state for each amino acid group in response to variations in individual
transporter activity with respect to the reference parameters (Table 2). Results
represent the sum of all amino acids in each group.compartment into the syncytiotrophoblast can occur for AcEx at very
low facilitated (Fig. 5d) or accumulative (Fig. 5a) transporter activity.
3.5. Interactions between multiple transporter activities
A series of simulations was performed in which two transporter ac-
tivities were varied simultaneously to explore their interactions. First,
the overall impact of exchanger activity on net placental transfer of
each amino acid was explored by varying bothMVM and BM exchanger
activities (Fig. 6). This showed that for amino acid AcEx, increasing ex-
change activity at the BM while reducing exchange activity at the
MVMwould result in optimal fetal delivery (i.e. by promoting exchange
to the fetus, while reducing back exchange to the maternal compart-
ment). In contrast, for ExF and AcExF, both of which are facilitative sub-
strates, increasing BM exchange activity could lead to reuptake into the
syncytiotrophoblast. Interestingly, for AcExF, the BM exchanger activity
had opposite effects on net transfer depending on whether the MVM
exchanger activity was high or low. It was shown that in addition to
having both exchanger activities high, additional high AcExF transfer
could occur when both activities were low. This is because for low ex-
change activities the accumulative and facilitative transporters would
dominate transfer, while back-exchange into the maternal and
syncytiotrophoblast compartments is limited. For Ex, higher fetal up-
take can be achieved by increasing both exchange activities, however,
the overall transfer remained relatively small.
Next it was investigated how overall transport is affected by the
transporters on the MVM, by simultaneously varying the accumulative
and MVM exchange activities (Fig. 7). The results showed that
maximum placental transfer of AcEx and AcExF occurred when the
accumulative activity is high, which promotes uptake into the
syncytiotrophoblast, and the exchange activity is low, which limits
back-exchange. For Ex and ExF, themaximum delivery in the fetal com-
partment was achieved when both transporter activities at the MVM
were high. This is because both transporters promote uptake via ex-
change into syncytiotrophoblast for these substrates, either directly or
indirectly by increasing the intracellular concentrations of the driving
substrates. Note that negative fetal delivery (transport out of the fetal
compartment into the syncytiotrophoblast) occurred under certain con-
ditions; for instance, for AcEx when the accumulative activity is low.
This occurred because low MVM uptake of AcEx meant that its ratio in
the syncytiotrophoblast was lower than on the fetal side, leading to re-
verse transport by BM exchange.
The impact of the transporter activities in the BM was evaluated
by varying the activities of the BM exchanger and facilitative trans-
porters (Fig. 8). The model suggested that for ExF and AcExF, the
fetal delivery was optimal when the facilitative activity was high
and the exchange activity at the BM was low. This combination pro-
moted transfer to the fetus, while at the same time limiting reuptake.
Additionally, it was shown that for AcEx and Ex, which are not sub-
strates of the facilitative transporter, the fetal delivery was increased
when all transport activities were high at the BM. These substrates
must be exchanged to transfer across the BM, therefore promoting
exchange will directly increase their transfer, and this is promoted
indirectly by increasing the facilitative activity, since this leads to a
more favourable exchange ratio.
3.6. Flow sensitivity
The impact of maternal and fetal blood ﬂow on placental transfer
was analysed for each amino acid group. Flow rates were only found
to be rate limiting when either maternal or fetal ﬂow approached
zero. The system appeared to be most sensitive to changes in the fetal
ﬂow due to its small volume fraction (Fig. 9). In contrast, the maternal
ﬂow did not appear to signiﬁcantly affect fetal delivery. The model sug-
gested that a slow fetal ﬂow rate translated to high fetal delivery for
AcEx and Ex (not facilitative substrates), while faster fetal ﬂow rate
Fig. 6. Effects of exchanger activity. Fetal venous–arterial difference at steady state for each amino acid group when the exchanger activities at the MVM and BM were varied
simultaneously.
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This is because for the facilitative substrates, high fetal ﬂow maintains
the BM concentration gradients driving facilitated transport. While forFig. 7. Effects of transporter activity at theMVM. Fetal venous–arterial difference at steady state f
activities simultaneously.amino acids that cannot be transported by facilitative transporters,
high fetal ﬂowwould maintain the less favourable inﬂux concentration
ratios, which determine transport by the exchangers.or each aminoacid groupwhenvarying theMVMexchanger and accumulative transporter
Fig. 8. Effects of transporter activity at the BM. Fetal venous–arterial difference at steady state for each amino acid group when varying the BM exchanger and facilitative transporter
activities simultaneously.
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The initial amino acid levels and input concentrations in the mater-
nal and fetal compartments were varied using the same factor for allFig. 9. Flow sensitivity analysis. Net transfer to the fetus for each amino acid groufour amino acid groups with respect to their reference concentrations
in Table 1. The results in Fig. 10 demonstrated that low fetal amino
acid levels and high maternal amino acid levels generally promoted
fetal transport, as would be expected. In addition, maternal aminop in response to varying the maternal and fetal ﬂow inputs simultaneously.
Fig. 10. Effect of amino acid input concentrations. Fetal venous–arterial difference for each amino acid group in response to varying the overall maternal and fetal amino acid arterial input
concentrations simultaneously. Note the concentrations of all amino acid groups were varied by the same factor.
1459N. Panitchob et al. / Biochimica et Biophysica Acta 1858 (2016) 1451–1461acids became limiting only at low levels. The results also showed that
negative net transfer could occur whenmaternal concentrations are ex-
tremely low and fetal concentrations are high.
3.8. Coordination of transporter activities
The model parameters were ﬁtted to determine which combination
of transporter activities would provide the best overall ﬁt of the fetal ve-
nous–arterial concentration differences from literature [7] (Table 3).
Compared to the reference simulations, ﬁtting improved results espe-
cially for substrates that were initially under-predicted. AcEx was
matched closely to the literature values (within 3.7%) and the low
level of Ex was increased substantially. However, for AcExF and ExF
the results deviated more from literature values than the original refer-
ence simulations. Compared to the reference parameters, the ﬁtted
transporter activities were adjusted by the following factors: accumula-
tive × 0.75, exchange at MVM × 2.8, exchange at BM × 59, and facilita-
tive activity × 1.3. This very large increase in BM exchanger activity
reﬂects the attempt by the algorithm to match amino acid Ex and its
low sensitivity.
3.9. Elevated maternal phenylalanine level
Finally, the model was used to explore the genetic condition of ma-
ternal phenylketonuria, where lack of phenylalanine hydroxylase
causes an excess level of phenylalanine that can affect fetal develop-
ment and function [37]. Phenylalanine is an exchange and facilitated
transporter substrate. Therefore, net transfer of each amino acid group
was modelled over a range of maternal ExF by including the additional
phenylalanine. The results showed that elevated concentrations of ExF
in the maternal compartment reduced the net transfer of all other
amino acid groups (Fig. 11). Moreover, the model predicted negative
net transfer of AcEx and Ex at high maternal phenylalanine concentra-
tions, which implies that these amino acids were transported out of
the fetal compartment.4. Discussion
This study developed an integrated modelling approach to explain
the interaction of transporters polarised to the microvillous apical and
basal plasma membranes of the human placental syncytiotrophoblast.
The modelling framework developed was effectively able to represent
the complexity arising from the interactions between multiple species
of amino acids and different types of transporters on both the MVM
and BM. This will prove invaluable in determining the contribution of
speciﬁc transporters to epithelial transport in the placenta and other
transport systems. The ability to predict how speciﬁc transporters con-
tribute to overall function will allow the design of targeted interven-
tions in epithelial transport disorders.
Themodelﬁrst successfully described the fundamental transporter in-
teractions at each of the placental plasma membranes separately, before
these were combined for the system as a whole. The accumulative-
exchange transporter conﬁguration at the MVM allowed the accumula-
tion of all the different types of amino acids into the syncytiotrophoblast.
Indirect stimulation of amino acids that were not substrates of the accu-
mulative transporter could be achieved by increasing the accumulative
transporter activity to promote exchange. The syncytiotrophoblast uptake
concentrations of both accumulative and exchange amino acid species
were substantially higher than thematernal concentrations. This accumu-
lation against the concentration gradient is enabled by the energy re-
quired to maintain the constant sodium gradient whose electrochemical
potential provides the driving force for the system. Similarly, the model
conﬁrmed that the facilitative-exchange transporter conﬁguration at the
BMwas sufﬁcient to ultimately transfer all amino acids to the fetus. In ad-
dition, indirect stimulation of amino acids thatwere not a substrate of the
facilitative transporter was shown to be possible by increasing the facili-
tated transport activity to promote exchange across the BM.
When the overall transfer across the placenta was considered using
physiological concentrations, the integrated model operated close to
steady state (Fig. 4) and showed a favourable net transfer of all amino
acid groups to the fetus (Table 3), in reasonable agreementwith literature
Fig. 11. Effects of elevated maternal phenylalanine concentrations in phenylketonuria for each amino acid group. Note ExF rises as it includes phenylalanine, but all other amino acids are
severely reduced. Normal phenylalanine levels are around 39 μmol l−1, while for classic untreated phenylketonuria this exceeds 1200 μmol l−1 [37]. For well managed pregnancies where
maternal phenylalanine is keptwithin theUK target rangeof 100–250 μmol l−1 themodelwould still predict a signiﬁcant reductionor even reversal in transfer of Ex, corresponding to threonine.
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sentation of placental amino acid transfer, despite many simplifying as-
sumptions. Fitting results suggested that the model predictions could be
improved by changing the activities for each transporter. Though, it ap-
peared difﬁcult to adjust independently the concentration of certain
amino acid groups without affecting the transfer of others. In particular,
improving the prediction for the exchange only substrate required a dis-
proportional increase in BM exchanger activity (Table 3).
Simultaneous variation of the transporter activities revealed thatmul-
tiple conﬁgurations could result in high transfer for certain amino acids
(AcExF in Fig. 6). Amino acids groups thatwere substrates of the accumu-
lative transporter (AcEx and AcExF) generally behaved in the same way
when considered at theMVM, in contrast with those that were not accu-
mulative transporter substrates (Ex and ExF, Fig. 7). Similarly, amino acid
groups that were substrates of the facilitative transporter (ExF and
AcExF) displayed the same response when observed at the BM, showing
a distinctly different response compared with those that were not
transported by the facilitative transporter (AcEx and Ex, Fig. 8). Against
a background where strategies are being developed to speciﬁcally target
placenta to deliver pharmacological or genetic therapies [38], modelling
may allow more informed decisions as to which transporters to target.
However, the differential effect on different amino acids by changing
transporter activity should serve as a cautionary warning that potential
unwanted side effects may be elicited by an intervention.
Simulation results were shown to be most sensitive to fetal, rather
than maternal ﬂow due to the low compartmental volume. However,
compared to the physiological reference values, increasing ﬂow further
did not lead to signiﬁcant changes in transfer (Fig. 9). Flow rates were
only shown to be rate limiting when either maternal or fetal ﬂow
rates approached zero. Under the given conditions, substrates of the fa-
cilitative transporter displayed a positive relationshipwith ﬂow,where-
as the other amino acids showed the opposite behaviour. Maternal
uterine and fetal umbilical blood ﬂows are one of the few placental pa-
rameters that can currently be measured in vivo and this model may
provide a basis for understanding their effect on the fetus.
It has to be emphasized that the current model was for the placenta
and did not include maternal or fetal metabolism, which will alter
amino acid availability in thematernal or fetal arteries. However, as dem-
onstrated by themodel, when overall maternal and fetal amino acid con-
centrations were varied, it was shown that placental transfer was
increased by both high maternal and low fetal concentrations of amino
acids, as would be expected. Nonetheless, placental transfer was mainly
controlled by fetal concentrations, suggesting that amino acid transfer
to the fetus is in part regulated by fetal demand. Furthermore, this
means that increasing overall maternal amino acid concentrationsabove physiological levels is unlikely to be an effective intervention strat-
egy. However, interventions could also speciﬁcally target changing the
relative amino acid composition which is important for exchanger func-
tion, as informed by the model. This is particularly relevant for inherited
diseases of metabolism that affect the concentration of speciﬁc amino
acids as shown by the model example of phenylketonuria, where mater-
nal phenylalanine levels can be over 30× higher than normal [37], se-
verely impairing placental transfer of other amino acids (Fig. 11).
It is important to consider the simplifying assumptions made in de-
riving the current model. In particular, amino acids were grouped ac-
cording to their speciﬁcity for the various transporter types and each
transporter type was modelled as a single representative transporter.
In reality, numerous different individual transporters can be distin-
guished for each transporter type, each of which is speciﬁc to certain
overlapping subsets of amino acids, with different substrate afﬁnities
[12]. In addition, since the main focus was on the function of the trans-
porters as a coordinated system, individual transporter models were
kept relatively simple, in order to capture faithfully the underlying
mechanisms for each type, while minimising the number of unknown
parameters. For example, translocation and binding were assumed
symmetric for the exchanger and facilitative transporter, however this
is not an intrinsic limitation and given enough available data this as-
sumption can be relaxed within the thermodynamic constraints for an
energetically passive transport process [21,23]. For the active accumula-
tive transporter the ultimate level of amino acid accumulation is deter-
mined by the sodiumelectrochemical potential difference, independent
of the kinetics. The effect of membrane potential was included for sodi-
um in the accumulative transporter, however an important limitation of
the current model was that Eqs. (4)–(6)only describe the transport of
neutral amino acids. Therefore the amino acid groups considered in
the present model should be subdivided further to speciﬁcally model
the transport of charged amino acids by transporters such as system
y+. In addition, placental metabolism was not considered in the
model, as the main focus was on transport; this could potentially
change the amount of amino acids available for transport and their rel-
ative composition. Another aspect not included in themodel was trans-
fer via paracellular routes, which are poorly understood anatomically
[39]. Paracellular diffusion will reduce the efﬁciency of the system be-
cause of high fetal amino acid concentrations, causing net diffusion in
the fetal to maternal direction. All compartments in the model were as-
sumed well-mixed, ignoring differences in local concentrations due to
the maternal intervillous and fetal capillary ﬂow. In addition, this im-
plied that the intracellular concentrations in the syncytiotrophoblast
were assumed uniform, rather than forming a gradient. Including diffu-
sion within the syncytiotrophoblast in the model did not affect results,
1461N. Panitchob et al. / Biochimica et Biophysica Acta 1858 (2016) 1451–1461as the estimated timescale for diffusion is fast compared to membrane
transport in our model (T = h2/D = 0.1 s, with thickness
h b 1× 10−5m and diffusion coefﬁcientD=1×10−9m2/s [40]). None-
theless, further compartmentalisation within the syncytiotrophoblast
could be important and this could lead to differences in the intracellular
concentrations determining transport at the BM and MVM.
While the model was designed for amino acids, the transporters in-
cluded in the model also transfer a wide range of other substances in-
cluding xenobiotics. As such, the modelling framework can be widely
applicable to transport functions both in the placenta and other
transporting epithelia; for instance intestinal absorption of nutrients
and drugs, reabsorption of nutrients from the renal tubules, and the
transfer of nutrients and drugs across the blood brain barrier [41].
In summary, a novel integrated modelling framework was devel-
oped for the placental amino acid transfer system as a whole. The
model was shown to be able to capture successfully the principal fea-
tures of the transfer system despite the necessary simplifying assump-
tions. Transporter modelling is currently limited by the availability of
speciﬁc details about individual transporters, their kinetics and sub-
strate speciﬁcity. However, one of the strengths of thismodelling frame-
work is that it can easily be updated as experimental data becomes
available. To illustrate the potential of the model for representing clini-
cal scenarios, the case of phenylketonuriawasmodelled; demonstrating
how elevatedmaternal phenylalaninewould restrict fetal delivery of all
other amino acids. Ultimately it is hoped that this type of modelling ap-
proacheswill inform biological understanding and aid the development
of targeted intervention strategies.
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